March 2005 in “Journal of The American Academy of Dermatology” Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.
27 citations
,
May 2016 in “British journal of dermatology/British journal of dermatology, Supplement” May 2025 in “International Journal of Dermatology”
January 2015 in “Hair transplant forum international” The document's conclusion cannot be provided because the content is not available.
33 citations
,
September 2020 in “Current Rheumatology Reports” Targeting adipocyte-to-mesenchymal transition could help treat fibrosis.
19 citations
,
March 2022 in “Molecular therapy. Nucleic acids” A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.
Obstructive Sleep Apnea does not significantly impact outcomes in non-cystic fibrosis bronchiectasis hospital stays.
Mechanical stress causes ligament thickening through WISP-1 and Hedgehog signaling.
3 citations
,
November 2024 in “Journal of the European Academy of Dermatology and Venereology” January 2026 in “Advances in Dermatology and Allergology” The study assessed the quality of life and psychological status of 83 patients with lichen planopilaris (LPP) and 79 patients with frontal fibrosing alopecia (FFA). It found that 34% of LPP patients and 19% of FFA patients experienced at least a moderate impact on their quality of life. Moderate or severe stress was reported by 42% of LPP patients and 31% of FFA patients, while mild depression was observed in 29% of LPP patients and 20% of FFA patients. Stress was identified as the most common perceived cause of the disease by 42% of both LPP and FFA patients. The study concludes that LPP and FFA patients may experience significant quality of life impairment and stress, which they believe contributes to their condition.
May 2025 in “Journal of the European Academy of Dermatology and Venereology” 82 citations
,
September 2020 in “Briefings in Bioinformatics” SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.
14 citations
,
April 2022 in “Molecules” Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.
October 2025 in “Cell Proliferation” IL10_ApoEVs improve skin healing and reduce scarring.
62 citations
,
May 2016 in “British journal of dermatology/British journal of dermatology, Supplement”
1 citations
,
January 2021 in “Journal of Cancer Therapy” Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.
1 citations
,
May 2020 in “Journal of The American Academy of Dermatology” The authors agree more research with proper control groups is needed to understand hair loss.
April 2017 in “The Journal of urology/The journal of urology” Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.
October 2025 in “Lasers in Medical Science” December 2024 in “JAAD International” July 2022 in “British Journal of Dermatology”
April 2023 in “Egyptian journal of Immunology” 10% hPL is best for growing mesenchymal stem cells, while 10% FBS is best for hepatocytes.
733 citations
,
September 2009 in “Journal of Cell Science” Wound healing is a complex, multi-phase process involving various cells and activities to repair skin damage.
488 citations
,
July 2021 in “Cell” Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.
299 citations
,
January 2018 in “Journal of Clinical Investigation” Different types of fibroblasts play various roles in diseases and healing, and more research on them could improve treatments.
248 citations
,
November 2011 in “The EMBO Journal” Wnt1/βcatenin signaling is crucial for heart repair after injury.
220 citations
,
March 2020 in “Advanced functional materials” Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.
215 citations
,
March 2011 in “Clinical Cancer Research” Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.